TPCN2 and neoplasm: As we observed a significant reduction in MHC-I expression in TPC2 KO tumours ex vivo (Figures 3A, B) and TPC2 KO cell in vitro (Figures 2A, C), we hypothesize that a reduction of MHC-I might be linked to downregulated ERK1/2 expression.